Susan Butcher had a stroke in 2012 and is supporting a new campaign from the Stroke Association which aims to reduce the number of strokes across Wales.
During February and March pharmacies across Wales are joining the Lower Your Risk of Stroke campaign, a partnership between Community Pharmacy Wales, Public Health Wales and the Stroke Association.
Gareth Davies had a stroke because of high blood pressure and is supporting a new campaign from the Stroke Association which aims to reduce the number of strokes across Wales.
This study will investigate whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury.
In this study we are testing the theory that by treating BP more intensively we will delay progression of the disease. We will also use state-of-the-art MRI imaging techniques to look at the mechanisms by which any beneficial effect of BP occurs.
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
This research is focused on assessing the relationship between the variability of the blood flow through the blood vessels supplying the brain, and the risk of stroke in patients who have already had a stroke or “mini-stroke” (TIA) in the past.
Reducing blood pressure to prevent bleeding complications and improve outcome following clot-busting treatment for ischaemic stroke
This year, the UK Stroke Assembly North event was held in Manchester. On day two, the morning plenary was all about stroke research, including how patients can get involved in shaping it.
The Stroke Association works with and for stroke survivors. We work with all stakeholders who have an interest in stroke, including the pharmaceutical industry, to achieve a common goal - to conquer stroke. Our guidelines ensure our approach to working with pharmaceutical companies is transparent and cannot compromise our independence.